Glaukos director awarded RSUs and stock options

GLAUKOS Corp director Denice Torres reported equity awards as part of standard board compensation.

Rhea-AI Filing Summary

GLAUKOS Corp director Denice Torres reported equity awards as part of standard board compensation. She received 1,878 restricted stock units that will vest in full on the one-year anniversary of the grant date and convert into the same number of common shares. She was also granted stock options for 2,987 shares of common stock with an exercise price of $53.57 per share, vesting in full after one year and expiring in 2036. Following these grants, she directly holds 24,212 shares of common stock, which include 4,609 restricted stock units that have not yet vested or been delivered.

Insider Trade Summary

Grant/Award: 4,865 shares

Grant/Award 2 txns

Insider Torres Denice

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	2,987	$0.00	$0.00
Grant/Award	Common Stock	1,878	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 2,987 contracts (Direct); Common Stock — 24,212 shares (Direct)

Footnotes (3)

1. F1. Represents a grant of restricted stock units received by the Reporting Person pursuant to the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock.
2. F2. Includes 4,609 restricted stock units that have not yet vested or been delivered to the Reporting Person.
3. F3. Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date

Key Figures

Restricted stock units granted: 1,878 units Stock options granted: 2,987 options Option exercise price: $53.57 per share +3 more

6 metrics

Restricted stock units granted 1,878 units Director grant vesting after one year

Stock options granted 2,987 options Director grant on May 28, 2026

Option exercise price $53.57 per share Stock Option (Right to Buy)

Common shares after transaction 24,212 shares Direct holdings following grants

Unvested RSUs included in holdings 4,609 units Restricted stock units not yet vested or delivered

Option expiration date May 28, 2036 Stock option term end

Key Terms

restricted stock units, Director Compensation Policy, Stock Option (Right to Buy), exercise price

4 terms

restricted stock units financial

"Represents a grant of restricted stock units received by the Reporting Person"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Director Compensation Policy financial

"received by the Reporting Person pursuant to the Issuer's Director Compensation Policy"

Stock Option (Right to Buy) financial

"security_title": "Stock Option (Right to Buy)""

exercise price financial

"conversion_or_exercise_price": "53.5700""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Glaukos (GKOS) director Denice Torres report in this Form 4?

Denice Torres reported receiving equity compensation awards from Glaukos. She was granted 1,878 restricted stock units and stock options for 2,987 shares, both vesting in full one year after the grant date under the company’s Director Compensation Policy.

How many restricted stock units did Denice Torres receive from Glaukos (GKOS)?

She received 1,878 restricted stock units as a grant under Glaukos’ Director Compensation Policy. These units will vest in full on the one-year anniversary of the grant date and will be settled in an equivalent number of Glaukos common shares.

What are the terms of the stock options granted to Denice Torres at Glaukos (GKOS)?

Torres was granted stock options covering 2,987 shares of Glaukos common stock at an exercise price of $53.57 per share. The options vest in full one year after the grant date and expire on May 28, 2036, if not exercised earlier.

How many Glaukos (GKOS) shares does Denice Torres hold after these transactions?

After the reported grants, Torres directly holds 24,212 shares of Glaukos common stock. This figure includes 4,609 restricted stock units that have not yet vested or been delivered, reflecting both vested and unvested equity interests reported in the filing.

Are the new Glaukos (GKOS) awards to Denice Torres cash transactions?

No, the awards are non-cash equity compensation. The 1,878 restricted stock units convert into shares upon vesting, and the 2,987 stock options allow share purchases at $53.57 per share after vesting, rather than involving immediate cash payments to acquire the awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/01/2026 - 06:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Torres Denice

(Last) (First) (Middle)

C/O GLAUKOS CORPORATION

ONE GLAUKOS WAY

(Street)

ALISO VIEJO CALIFORNIA 92656

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GLAUKOS Corp [ GKOS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/28/2026		A		1,878(1)	A	$0	24,212(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$53.57	05/28/2026		A		2,987		05/28/2027(3)	05/28/2036	Common Stock	2,987	$0	2,987	D

Explanation of Responses:

1. Represents a grant of restricted stock units received by the Reporting Person pursuant to the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock.

2. Includes 4,609 restricted stock units that have not yet vested or been delivered to the Reporting Person.

3. Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date

	Diana Scherer, Attorney-in-Fact	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)